1:01Mount Sinai celebrates lives of former preemies at 'Out of the world' party1:39Most babies should be exposed to peanuts earlier, according to new guidelines1:04
Feb. 21 (UPI) -- Researchers at King's College London are using apolipoproteins to diagnose cardiovascular disease at an earlier stage. ApoE, apoC2 and apoC3 have a stronger association with cardiovascular disease than apoA1 and apoB. "These unexpected strong associations of VLDL-associated apolipoproteins with cardiovascular disease provide support to expanding the current measurements of apolipoproteins and to the concept of targeting additional apolipoproteins to reduce risk." Results showed apoC3 as a main therapeutic target for lowering VLDL to reduce excess cardiovascular risk related to high VLDL. The study found that these apolipoproteins are linked to very low-density lipoproteins, or VLDL, and another type of fat known as trigliycerides.
collected by :Lucy William
No comments:
Post a Comment